Multiple delivery technologies selected by technical feasibility, regulatory framework and production scalability — coordinated across specialized European laboratories.
We work with multiple delivery systems depending on the formulation, active compounds and desired absorption profile. Each system is selected based on technical feasibility, regulatory framework and production scalability across European laboratories.
Each technology serves a specific formulation purpose. Selection is driven by the active compounds, target bioavailability and the regulatory and production context of each project.
Vegan HPMC capsules designed for controlled gastrointestinal release, supported by a functional inulin-based matrix. This system ensures stable formulations and consistent dosing, while maintaining clean-label standards and compatibility with a wide range of active compounds.
Encapsulation of active compounds within phospholipid structures, protecting sensitive ingredients and improving their bioavailability. Commonly used for liquid formats where stability and absorption efficiency are critical.
Designed to optimize absorption of fat-soluble compounds through oil-based carriers and natural transport pathways. Particularly effective for vitamins and compounds that require enhanced intestinal absorption.
Designed for rapid solubility and immediate intake, allowing flexible dosing and convenient consumption formats. Suitable for formulations where speed of absorption and ease of use are key factors.
In many cases, a single product strategy requires multiple delivery systems. We coordinate production across specialized laboratories to ensure each format is developed, produced and aligned within the same product architecture.
This allows brands to scale across formats without fragmentation.
Delivery systems are matched to active compounds, target bioavailability and the regulatory context of each market.
Each format is assigned to the appropriate specialized laboratory within our European network.
All formats are developed and produced under a single coordinated product strategy — no fragmentation between suppliers.
Delivery systems are not selected in isolation. They are integrated into a broader process that includes formulation, laboratory selection, regulatory alignment and production coordination — ensuring every product is technically viable and scalable within a European manufacturing framework.
Active compounds, dosage and compatibility requirements are defined before any delivery system is selected. Technical feasibility drives every decision.
The appropriate laboratory is identified based on the delivery system, production volume and required certifications within our European network.
Each delivery system is reviewed against EU regulatory requirements — Novel Food, EFSA health claims, labelling — before production begins.
Production is managed as a single coordinated process, regardless of the number of formats or laboratories involved, with full documentation at every stage.
We can help you select and coordinate the right delivery systems across specialized laboratories. Contact us to evaluate feasibility and production strategy.
